David Bellinger, PhD
| Department | Neurology |
 |
| Hospital Title | Senior Research Associate in Neurology | |
| Academic Title | Professor of Neurology | |
| Phone | 617-355-6565 | |
| Fax | 617-730-0618 | |
| David Bellinger | ||
| Location |
300 Longwood Avenue Farley-Basement Boston MA 02115 |
Research Overview
Our laboratory focuses on two types of early insults to the developing nervous system-- chemical exposures (e.g., lead, elemental mercury, methylmercury, arsenic, manganese, pesticides and anesthetic agents) and insults related to serious medical conditions (e.g., congenital heart lesions, schistosomiasis and congenital diaphragmatic hernia).
The specific aims of the chemical exposure studies are to:
- Develop new strategies for quantifying exposure.
- Define the "behavioral signature," if any, associated with different exposures and exposure scenarios.
- Identify factors that either increase or decrease an individual's risk associated with exposure to a chemical.
The goal of the studies on endogenous insults related to medical conditions is to characterize the associated behavioral risks, particularly risks associated with drug therapies or with invasive interventions, such as procedures to repair serious congenital heart disease.
About David Bellinger
David Bellinger has a PhD in Psychology from Cornell University and a Master's degree in Epidemiology from the Harvard School of Public Health. He holds a secondary appointment as Professor in the Department of Environmental Health at the Harvard School of Public Health. He is currently President of the International Society for Children's Health and the Environment.
Key Publications
- Bellinger DC, Newburger JW. Neuropsychological, psychosocial, and quality-of-life outcomes in children and adolescents with congenital heart disease. Progress in Pediatric Cardiology 2010; 29:87-92.
- Bellinger DC. Interpreting epidemiologic studies of developmental neurotoxicity: Conceptual and analytic issues. Neurotoxicology and Teratology 2009; 31:267-74.
- Bouchard M, Weuve J, Weisskkopf M, Matthews JA, Schwartz J, Gilman S, Bellinger DC. Blood lead levels and major depressive disorder, panic disorder, and generalized anxiety disorder in U.S. young adults. Archives of General Psychiatry 2009; 66:1313-1319.
- Bellinger DC, Editor. Human Developmental Neurotoxicology. New York: Taylor and Francis Group, 2006.
For a list of David Bellinger's publications on PubMed, click here.
